Zobrazeno 1 - 10
of 91
pro vyhledávání: '"national immunisation programme"'
Autor:
Régis Verdier, Clarisse Marchal, Manon Belhassen, Marie Le Pannerer, Nicole Guiso, Robert Cohen
Publikováno v:
Infectious Medicine, Vol 2, Iss 1, Pp 51-56 (2023)
The French National Immunization Program was updated in 2013 for vaccination against diphtheria, tetanus, pertussis, and poliomyelitis. Our previous findings on the evolution of age-specific booster vaccination coverage rates (VCRs) up to 2017 sugges
Externí odkaz:
https://doaj.org/article/f2e16c53382e4b1999cfa1452fbc544f
Autor:
Alex J. J. Lister, Cheng Foh Le, Eddy Seong Guan Cheah, Mohd Nasir Mohd Desa, David W. Cleary, Stuart C. Clarke
Publikováno v:
Pneumonia, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background Pneumococcal pneumonia is the leading cause of under-five mortality globally. The surveillance of pneumococcal serotypes is therefore vital for informing pneumococcal vaccination policy and programmes. Pneumococcal conjugate vacci
Externí odkaz:
https://doaj.org/article/ad707f7e1c5d497591f8b20926ef6650
Autor:
Ronan Lemwel Valdecantos, Raffaele Palladino, Andrea Lo Vecchio, Emma Montella, Maria Triassi, Antonio Nardone
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1390 (2022)
Despite the implementation of widespread vaccination programs, the European Health Systems continue to experience care challenges attributable to organizational and structural issues. This study aimed to review the available data on aspects within th
Externí odkaz:
https://doaj.org/article/de093ca6703c4617b1701b029e225629
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Health Policy and Management, Vol 4, Iss 11, Pp 757-761 (2015)
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programm
Externí odkaz:
https://doaj.org/article/70473fe61e1c4fffae844aa73581d3b1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
The incidence of most respiratory-transmitted diseases decreased during the COVID-19 pandemic as a result of containment measures. In contrast, in the Netherlands we noted an increase in invasive disease caused by Haemophilus influenzae b (Hib) (from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::6b09a20556a9457a8890666741e9a8ff
Autor:
Steens, Anneke, Stanoeva, Kamelia R, Knol, Mirjam J, Mariman, Rob, de Melker, Hester E, van Sorge, Nina M
The incidence of most respiratory-transmitted diseases decreased during the COVID-19 pandemic as a result of containment measures. In contrast, in the Netherlands we noted an increase in invasive disease caused by Haemophilus influenzae b (Hib) (from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::cf02681afc0fdc3ce01ed606e155f7f5
http://hdl.handle.net/10029/625377
http://hdl.handle.net/10029/625377
Publikováno v:
Eurosurveillance
The incidence of most respiratory-transmitted diseases decreased during the COVID-19 pandemic as a result of containment measures. In contrast, in the Netherlands we noted an increase in invasive disease caused by Haemophilus influenzae b (Hib) (from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8435bba1f919c358d33d2570ebeef607
https://pubmed.ncbi.nlm.nih.gov/34676819
https://pubmed.ncbi.nlm.nih.gov/34676819
Autor:
Stuart C. Clarke, Mohd Nasir Mohd Desa, Cheng Foh Le, Eddy Seong Guan Cheah, Alex Lister, David W. Cleary
Publikováno v:
Pneumonia
Pneumonia, Vol 13, Iss 1, Pp 1-14 (2021)
Pneumonia, Vol 13, Iss 1, Pp 1-14 (2021)
Background Pneumococcal pneumonia is the leading cause of under-five mortality globally. The surveillance of pneumococcal serotypes is therefore vital for informing pneumococcal vaccination policy and programmes. Pneumococcal conjugate vaccines (PCVs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4916824e55ffecc6ac43813373ce6038
https://doi.org/10.1186/s41479-021-00086-7
https://doi.org/10.1186/s41479-021-00086-7